Eli Lilly just struck a major deal with the world's largest retailer. GLP-1 drugs may have uses beyond obesity and diabetes ...
Zacks.com on MSN
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...
Last year, China-based Jiangsu Hengrui Pharmaceuticals overtook the U.K.’s AstraZeneca as the top clinical trial sponsor in ...
Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...
The summit unites global leaders focused on turning ideas into action and fostering partnerships for lasting impact in health.
Pfizer and Novo Nordisk continue to fight for ownership of obesity startup Metsera; CDER Director George Tidmarsh leaves his ...
Novo Nordisk reported third-quarter financial results on Wednesday. The transcript from the company's earnings call has been ...
The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their weight loss drugs at a lower price through TrumpRx.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback